Immunoglobulin (IgG) and (IgM) Antibody Responses to Rabies Vaccine

References

1. Atanasiu P. 1973; Quantitative assay and potency test of antirabies serum and immunoglobulin. In Laboratory Techniques in Rabies 3rd edition, Monograph Series, no. 23, pp 314–318 Edited by Kaplan M. M., Koprowski H. Geneva World Health Organization;
   [Google Scholar]
2. Baer G. M. 1975 In The Natural History of Rabies vol 1 pp 181–198 Edited by Baer G. New York & London: Academic Press;
   [Google Scholar]
3. Baer G. M., Cleary W. F. 1972; A model in mice for the pathogenesis and treatment of rabies. Journal of Infectious Diseases 125:520–527
   [Google Scholar]
4. Baer G. M., Yager P. A. 1977; A mouse model for post-exposure rabies prophylaxis: the comparative efficacy of two vaccines and of antiserum administration. The Journal of General Virology 36:51–58
   [Google Scholar]
5. Balthazard M., Bahmanyar M., Ghodssi M., Sabeti A., Gajdusek C., Rauzbehi E. 1955; Essai practique du sérum antirabique chez les mordus par loups enrages. Bulletin of the World Health Organization 13:747–772
   [Google Scholar]
6. Blinkoff R. C. 1966; IgM and IgG antibodies in mice: dissociation of the normal immunoglobulin sequence. Journal of Immunology 97:736–746
   [Google Scholar]
7. Britton S., Möller G. 1968; Regulation of antibody synthesis against Escherichia coli endotoxin 1. Suppressive effect of endogenously produced and passively transferred antibodies. Journal of Immunology 100:1326–1334
   [Google Scholar]
8. Cho H. C., Fenje P., Sparkes J. D. 1972; Antibody and immunoglobulin response to antirabies vaccination in man. Infection & Immunity 6:483–486
   [Google Scholar]
9. Coe J. E., Bell J. F. 1977; Antibody response to rabies virus in Syrian hamsters. Infection & Immunity 16:915–919
   [Google Scholar]
10. Emmons R. W., Leonard L. L., Degenaro F. Jun, Protas S., Bazely P. L., Giammona S. T., Sturckow K. 1973; A case of human rabies with prolonged survival. Intervirology 1:60–72
    [Google Scholar]
11. Fujisaki Y., Sekiguchi K., Hirasawa K. 1968; 19S neutralizing antibody produced in guinea pigs by rabies virus. National Institute of Animal Health Quarterly, Tokyo 8:132–139
    [Google Scholar]
12. Grandien M., Espmark A. 1974; Follow up of antibody response after post-exposure rabies immunization. Proceedings of the International Symposium on Rabies, Lyon, 1972. Symposium Series in Immunobiological Standardization vol 21: pp 243–252 Basel: S. Karger;
    [Google Scholar]
13. Habel K. 1973; Habel test for potency. In Laboratory Techniques in Rabies 3rd edition, Monograph Series, no. 23, pp 276–277 Edited by Kaplan M. M., Koprowski H. Geneva World Health Organization;
    [Google Scholar]
14. Hattwick M. A. W., Gregg M. B. 1975 In The Natural History of Rabies vol 11 p 289 Edited by Baer G. New York and London: Academic Press;
    [Google Scholar]
15. Hauser R., Keller F., Steck F., Wandeler A. I. 1978; IgM and IgG antibody profiles after immunization of man with HDCS-rabies vaccine. In Developments in Biological Standardization Joint WHO/IABS symposium on Standardization of Rabies Vaccine for Human use produced in Tissue Cultures, Marburg, November, 1977 vol 40: pp 137–139
    [Google Scholar]
16. Janeway C. A., Rosen F. S., Merler E., Alper C. A. 1967 In The Gamma Globulins London: Churchill;
    [Google Scholar]
17. Jenkin C. R., Auzins I., Reade P. C. 1965; The synthesis of macroglobulin antibody to a bacterial antigen in mice after treatment with thorotrast. Australian Journal of Experimental Biology & Medical Science 43:607–624
    [Google Scholar]
18. Killander J. 1964; Separation of human heme & hemoglobin-binding plasma proteins, ceruloplasmin and albumin by gel filtration. Biochimica et Biophysica Acta 93:1–14
    [Google Scholar]
19. Maton P. N., Pollard J. D., Newsom-Davis J. 1976; Human rabies encephalomyelitis. British Medical Journal 1:1038–1040
    [Google Scholar]
20. Mims C. A. 1976 In The Pathogenesis of Infectious Disease p 96 London: Academic Press;
    [Google Scholar]
21. Miranda J. J. 1972; Studies on immunological paralysis. IX. The immunogenicity and tolerogenicity of Levan (polyfructose) in mice. Immunology 23:829–842
    [Google Scholar]
22. Monath T. P. C. 1971; Neutralizing antibody responses in the major immunoglobulin classes to yellow fever 17D vaccination of humans. American Journal of Epidemiology 99:122–129
    [Google Scholar]
23. Murphy F. A. 1977; Rabies pathogenesis. Archives of Virology 54:279–297
    [Google Scholar]
24. Pike R. M. 1967; Antibody heterogenicity and serological reactions. Bacteriological Reviews 31:157–174
    [Google Scholar]
25. Prochazka O., Hronovsky V., Dubanska H. 1972; The dynamics of formation of virus-neutralizing, complement fixing and immunofluorescent antibodies to the rabies virus in guinea pigs. Folia micro-biologica 17:105–111
    [Google Scholar]
26. Rager-Zisman B., Allison A. C. 1973; Effects of immunosuppression on Coxsackie B-3 virus infection in mice and passive protection by circulatory antibody. Journal of General Virology 19:339–351
    [Google Scholar]
27. Rubin R. H., Sullivan L., Summers R., Gregg M. B., Sikes R. K. 1970; A case of human rabies in Kansas: epidemiologic, clinical, and laboratory considerations. The Journal of Infectious Diseases 122:318–322
    [Google Scholar]
28. Rubin R. H., Dierks R. E., Gough P., Gregg M. B., Gerlach E. H., Sikes R. K. 1971; Immunoglobulin response to rabies vaccine in man. Lancet ii:625–628
    [Google Scholar]
29. Sahier K., Schwartz R. S. 1965; The immunoglobulin sequence. i. Arrest by 6-mercaptopurine and restitution by antibody, antigen or splenectomy. Journal of Immunology 95:345–354
    [Google Scholar]
30. Seligman E. B. 1973; The NIH test for potency. In Laboratory Techniques in Rabies 3rd edition, Monograph Series no. 23, pp 279–286 Edited by Kaplan M. M., Koprowski H. Geneva World Health Organization;
    [Google Scholar]
31. Sikes R. K., Cleary W. F., Koprowski H., Wiktor T. J., Kaplan M. M. 1971; Effective protection of monkeys against death from street virus by post exposure administration of tissue culture rabies vaccine. Bulletin of the World Health Organization 45:1–11
    [Google Scholar]
32. Spiegelburg H. 1974; Biological activities of immunoglobulins of different classes and subclasses. Advances in Immunology 19:259–289
    [Google Scholar]
33. Svehag S. E., Mandel B. 1963; The formation & properties of poliovirus-neutralizing antibody. 1.19S and 7S antibody formation: difference in kinetics and antigen dose requirement for induction. Journal of Experimental Medicine 119:1–19
    [Google Scholar]
34. Thraenhart O., Kuwert E. K. 1977; Enzyme immuno-assay for demonstration of rabies-virus antibodies after immunization. Lancet ii:388–400
    [Google Scholar]
35. Tignor G., Shope R. E. 1972; Vaccination & challenge of mice with viruses of the rabies sero-group. Journal of Infectious Diseases 125:322–327
    [Google Scholar]
36. Tignor G., Mifune K., Smith A. L. 1976; The immunopathology of rabies. In Symposium on Advances in Rabies Research pp 13–14 Atlanta: U.S. Dept. of Health, Education & Welfare;
    [Google Scholar]
37. Uhr J. W., Finkelstein M. S. J. 1963; Antibody formation. IV. Formation of rapidly and slowly sedimenting antibodies and immunological memory to bacteriophage X 174. Journal of Experimental Medicine 117:457–477
    [Google Scholar]
38. Uhr J. W., Finkelstein M. S. 1967; The kinetics of antibody formation. Progress in Allergy 10:37–83
    [Google Scholar]
39. Williams C. A., Chase M. W. 1968 In Methods in Immunology and Immunochemistry vol 2: chapter 7, pp 103–105 New York: Academic Press;
    [Google Scholar]
40. W.H.O. Expert Committee on Rabies 5th Report 1966 Technical report series No. 32 Geneva World Health Organisation.;
    [Google Scholar]